A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
NCT ID: NCT03573908
Last Updated: 2020-12-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
614 participants
INTERVENTIONAL
2018-06-20
2019-04-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Linaclotide 290 µg
Participants receive linaclotide 290 µg orally once daily for 12 weeks during the Treatment Period. At Week 12 participants are rerandomized to receive either linaclotide 290 µg or placebo for 4 weeks in the Randomized Withdrawal Period.
Linaclotide
Oral capsule
Placebo
Matching placebo oral capsule
Placebo
Participants receive placebo to linaclotide orally once daily for 12 weeks during the Treatment Period. At Week 12 participants are switched to receive linaclotide 290 µg for 4 weeks during the Randomized Withdrawal Period.
Linaclotide
Oral capsule
Placebo
Matching placebo oral capsule
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Linaclotide
Oral capsule
Placebo
Matching placebo oral capsule
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female patients of childbearing potential must agree to use one of the following methods of birth control:
1. Hormonal contraception
2. Double-barrier birth control
3. Maintenance of a monogamous relationship with a male partner who has been surgically sterilized by vasectomy
* Patient meets protocol criteria for diagnosis of IBS-C
* Patient demonstrates continued IBS-C symptoms through Pretreatment Period
* Patient maintains a minimum level of compliance with daily diary
Exclusion Criteria
* Patient has symptoms of or been diagnosed with a medical condition that may contribute to abdominal pain
* Patient has a structural abnormality of the gastrointestinal (GI) tract or a disease or condition that can affect GI motility
* Patient has any protocol-excluded or clinically significant medical or surgical history that could confound the study assessments
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Allergan Sales, LLC
INDUSTRY
Ironwood Pharmaceuticals, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wilmin Bartolini, PhD
Role: STUDY_CHAIR
Ironwood Pharmaceuticals, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Research Associates
Huntsville, Alabama, United States
Elite Clinical Studies
Phoenix, Arizona, United States
Adobe Clinical Research, LLC
Tucson, Arizona, United States
Arkansas Gastroenterology
North Little Rock, Arkansas, United States
GW Research, Inc.
Chula Vista, California, United States
Kindred Medical Institute for Clinical Trials, LLC
Corona, California, United States
Diagnamics, Inc.
Encinitas, California, United States
MD Studies, Inc.
Fountain Valley, California, United States
Paragon Rx Clinical, Inc. - Garden Grove
Garden Grove, California, United States
Grossmont Center For Clinical Research
La Mesa, California, United States
Facey Medical Foundation
Mission Hills, California, United States
Providence Clinical Research
North Hollywood, California, United States
Precision Research Institute
San Diego, California, United States
Paragon Rx Clinical, Inc.- Santa Ana
Santa Ana, California, United States
Millennium Clinical Trials
Thousand Oaks, California, United States
St. Joseph Heritage Healthcare
Yorba Linda, California, United States
Connecticut Clinical Research Institute
Bristol, Connecticut, United States
Chase Medical Research, LLC
Waterbury, Connecticut, United States
Clinical Research of South Florida
Coral Gables, Florida, United States
Avail Clinical Research, LLC
DeLand, Florida, United States
Palmetto Research, LLC
Hialeah, Florida, United States
Nature Coast Clinical Research, LLC
Inverness, Florida, United States
The Chappel Group Research
Kissimmee, Florida, United States
Jesscan Medical Research
Miami, Florida, United States
Well Pharma Medical Research Corporation
Miami, Florida, United States
New Horizon Research Center
Miami, Florida, United States
San Marcus Research Clinic, Inc.
Miami Lakes, Florida, United States
Ocean Blue Medical Research Center, Inc.
Miami Springs, Florida, United States
Ormond Medical Arts Pharmaceutical Research Center
Ormond Beach, Florida, United States
Precision Clinical Research
Sunrise, Florida, United States
Meridien Research - Tampa
Tampa, Florida, United States
Palm Beach Research Center
West Palm Beach, Florida, United States
Research Institute of Central Florida, LLC
Winter Park, Florida, United States
Mount Vernon Clinical Research, LLC
Sandy Springs, Georgia, United States
Clinical Trials Management, LLC
Metairie, Louisiana, United States
Delta Research Partners, LLC
Monroe, Louisiana, United States
Louisiana Research Center, LLC
Shreveport, Louisiana, United States
Alan A. Rosen, MD, PA
Baltimore, Maryland, United States
Meritus Center For Clinical Research
Hagerstown, Maryland, United States
Boston Clinical Trials, Inc.
Boston, Massachusetts, United States
MedVadis Research Corporation
Watertown, Massachusetts, United States
Gastroenterology Associates of West Michigan
Wyoming, Michigan, United States
Gastrointestinal Associates PA
Flowood, Mississippi, United States
St. Louis Center For Clinical Research
St Louis, Missouri, United States
Bozeman Health Deaconess Hospital
Bozeman, Montana, United States
Clinical Research of South Nevada
Las Vegas, Nevada, United States
Healthwise Medical Associates
Brooklyn, New York, United States
Long Island Gastrointestinal Research Group, LLP
Great Neck, New York, United States
Carolina Digestive Health Associates
Charlotte, North Carolina, United States
Carolina Digestive Health Associates
Concord, North Carolina, United States
Cumberland Research Associates
Fayetteville, North Carolina, United States
Peters Medical Research, LLC
High Point, North Carolina, United States
Wake Research Associates, LLC
Raleigh, North Carolina, United States
PMG Research of Wilmington
Wilmington, North Carolina, United States
Clinical Trials of America - North Carolina, LLC
Winston-Salem, North Carolina, United States
Lyndhurst Clinical Research
Winston-Salem, North Carolina, United States
PMG Research of Winston-Salem
Winston-Salem, North Carolina, United States
Lillestol Research
Fargo, North Dakota, United States
Hightop Medical Research Center
Cincinnati, Ohio, United States
New Horizons Clinical Research
Cincinnati, Ohio, United States
Remington Davis, Inc.
Columbus, Ohio, United States
Dayton Gastroenterology, Inc.
Dayton, Ohio, United States
Hometown Urgent Care and Research
Dayton, Ohio, United States
Great Lakes Gastroenterology Research, LLC
Mentor, Ohio, United States
IPS Research Company
Oklahoma City, Oklahoma, United States
Partners In Clinical Research
Cumberland, Rhode Island, United States
Mountain View Clinical Research, Inc.
Greer, South Carolina, United States
Meridian Clinical Research
Dakota Dunes, South Dakota, United States
ClinSearch, LLC
Chattanooga, Tennessee, United States
New Phase Research & Development
Knoxville, Tennessee, United States
MW Clinical Research Center
Beaumont, Texas, United States
Southwest Clinical Trials
Houston, Texas, United States
Southwest Clinical Trials
Houston, Texas, United States
Quality Research, Inc.
San Antonio, Texas, United States
Diagnostics Research Group
San Antonio, Texas, United States
Stone Oak, LLC dba Discovery Clinical Trials
San Antonio, Texas, United States
Advanced Research Institute
Ogden, Utah, United States
New River Valley Research Institute
Christiansburg, Virginia, United States
Blue Ridge Medical Research
Lynchburg, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Brenner DM, Lacy BE, Ford AC, Bartolini W, Wu J, Shea EP, Bochenek W, Boinpally R, Almansa C. Linaclotide Reduced Response Time for Irritable Bowel Syndrome With Constipation Symptoms: Analysis of 4 Randomized Controlled Trials. Am J Gastroenterol. 2023 May 1;118(5):872-879. doi: 10.14309/ajg.0000000000002064. Epub 2022 Oct 12.
Chang L, Lacy BE, Moshiree B, Kassebaum A, Abel JL, Hanlon J, Bartolini W, Boinpally R, Bochenek W, Fox SM, Mallick M, Tripp K, Omniewski N, Shea E, Borgstein N. Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System. Am J Gastroenterol. 2021 Sep 1;116(9):1929-1937. doi: 10.14309/ajg.0000000000001334.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCP-103-312
Identifier Type: -
Identifier Source: org_study_id